| [1] |
2023 Alzheimer's disease facts and figures[J]. Alzheimers Dement, 2023, 19(4): 1598-1695. DOI: 10.1002/alz.13016.
|
| [2] |
GBD 2019 Dementia Forecasting Collaborators. Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019[J]. Lancet Public Health, 2022, 7(2): e105-125.
|
| [3] |
JIA L F, DU Y F, CHU L, et al. Prevalence, risk factors, and management of dementia and mild cognitive impairment in adults aged 60 years or older in China: a cross-sectional study[J]. Lancet Public Health, 2020, 5(12): e661-671.
|
| [4] |
PASSERI E, ELKHOURY K, MORSINK M, et al. Alzheimer's disease: treatment strategies and their limitations[J]. Int J Mol Sci, 2022, 23(22): 13954. DOI: 10.3390/ijms232213954.
|
| [5] |
BADJI A, YOUWAKIM J, COOPER A, et al. Vascular cognitive impairment-Past, present, and future challenges[J]. Ageing Res Rev, 2023, 90: 102042. DOI: 10.1016/j.arr.2023.102042.
|
| [6] |
|
| [7] |
JUUL RASMUSSEN I, QVIST THOMASSEN J, FRIKKE-SCHMIDT R. Impact of metabolic dysfunction on cognition in humans[J]. Curr Opin Lipidol, 2021, 32(1): 55-61.
|
| [8] |
LIVINGSTON G, HUNTLEY J, LIU K Y, et al. Dementia prevention, intervention, and care: 2024 report of the lancet standing commission[J]. Lancet, 2024, 404(10452): 572-628. DOI: 10.1016/S0140-6736(24)01296-0.
|
| [9] |
刘通达,郝志梅. 基于CHARLS 2020的我国中老年人慢性病及共病现状分析[J]. 老年医学研究, 2025, 6(4): 17-22.
|
| [10] |
HU F F, CHENG G R, LIU D, et al. Population-attributable fractions of risk factors for all-cause dementia in China rural and urban areas: a cross-sectional study[J]. J Neurol, 2022, 269(6): 3147-3158. DOI: 10.1007/s00415-021-10886-y.
|
| [11] |
GAN J H, ZENG Y, HUANG G W, et al. The updated prevalence and risk factors of dementia in old adults in China: a cross-sectional study[J]. J Alzheimers Dis, 2024, 102(4): 1209-1223.
|
| [12] |
FABBRI M, BERACCI A, MARTONI M, et al. Measuring subjective sleep quality: a review[J]. Int J Environ Res Public Health, 2021, 18(3): 1082. DOI: 10.3390/ijerph18031082.
|
| [13] |
GRECO C, DI GENNARO F, D'AMATO C, et al. Validation of the Composite Autonomic Symptom Score 31 (COMPASS 31) for the assessment of symptoms of autonomic neuropathy in people with diabetes[J]. Diabet Med, 2017, 34(6): 834-838.
|
| [14] |
张知音,马瑜瑾,付留俊,等. 复合自主神经症状评分-31在糖尿病心血管自主神经病变中的诊断价值[J]. 中国临床医学, 2020, 27(2): 229-234.
|
| [15] |
郭起浩,洪震. 神经心理评估[M]. 2版. 上海: 上海科学技术出版社, 2016.
|
| [16] |
LANE C A, HARDY J, SCHOTT J M. Alzheimer's disease[J]. Euro J Neurology, 2018, 25(1): 59-70.
|
| [17] |
KATZ S, DOWNS T D, CASH H R, et al. Progress in development of the index of ADL[J]. Gerontologist, 1970, 10(1): 20-30.
|
| [18] |
PETERSEN R C. Mild cognitive impairment as a diagnostic entity[J]. J Intern Med, 2004, 256(3): 183-194.
|
| [19] |
中国痴呆与认知障碍指南写作组,中国医师协会神经内科医师分会认知障碍疾病专业委员会. 2018中国痴呆与认知障碍诊治指南(一):痴呆及其分类诊断标准[J]. 中华医学杂志, 2018, 98(13): 965-970.
|
| [20] |
中国痴呆与认知障碍诊治指南写作组,中国医师协会神经内科医师分会认知障碍疾病专业委员会. 2018中国痴呆与认知障碍诊治指南(五):轻度认知障碍的诊断与治疗[J]. 中华医学杂志, 2018, 98(17): 1294-1301.
|
| [21] |
道日敖,田园,陈焕,等. 术后返回ICU患者亚急性和慢性疼痛发生率及影响因素分析[J]. 协和医学杂志, 2024, 15(3): 598-603.
|
| [22] |
黎艳娜,王艺桥. 我国老年人慢性病共病现状及模式研究[J]. 中国全科医学, 2021, 24(31): 3955-3962, 3978.
|
| [23] |
王梅杰,周翔,李亚杰,等. 2010—2019年中国中老年人慢性病共病患病率的Meta分析[J]. 中国全科医学, 2021, 24(16): 2085-2091.
|
| [24] |
章轶立,黄馨懿,齐保玉,等. 老年人群共病问题现状挑战与应对策略[J]. 中国全科医学, 2022, 25(35): 4363-4368.
|
| [25] |
杨曦,杨星,杨敬源,等. 贵州省农村老年人睡眠障碍对认知功能损害影响[J]. 中国公共卫生, 2021, 37(8): 1233-1236.
|
| [26] |
韩利知. 老年人失眠现况及相关因素的临床研究[D]. 上海: 上海交通大学, 2016.
|
| [27] |
张芮仙,张善东,齐涵,等. 老年人睡眠障碍的影响因素及对机体免疫状态、认知功能和生活质量的影响[J]. 现代生物医学进展, 2022, 22(21): 4071-4075.
|
| [28] |
TULLY P J, HANON O, COSH S, et al. Diuretic antihypertensive drugs and incident dementia risk: a systematic review, meta-analysis and meta-regression of prospective studies[J]. J Hypertens, 2016, 34(6): 1027-1035.
|
| [29] |
DING J, DAVIS-PLOURDE K L, SEDAGHAT S, et al. Antihypertensive medications and risk for incident dementia and Alzheimer's disease: a meta-analysis of individual participant data from prospective cohort studies[J]. Lancet Neurol, 2020, 19(1): 61-70. DOI: 10.1016/S1474-4422(19)30393-X.
|
| [30] |
MCGRATH E R, BEISER A S, DECARLI C, et al. Blood pressure from mid- to late life and risk of incident dementia[J]. Neurology, 2017, 89(24): 2447-2454.
|
| [31] |
CANNISTRARO R J, BADI M, EIDELMAN B H, et al. CNS small vessel disease: a clinical review[J]. Neurology, 2019, 92(24): 1146-1156. DOI: 10.1212/WNL.0000000000007654.
|
| [32] |
MORETTI R, CARUSO P. Small vessel disease-related dementia: an invalid neurovascular coupling[J]. Int J Mol Sci, 2020, 21(3): 1095. DOI: 10.3390/ijms21031095.
|
| [33] |
ZHAO X H, XU X L, YAN Y F, et al. Independent and joint associations of cardiometabolic multimorbidity and depression on cognitive function: findings from multi-regional cohorts and generalisation from community to clinic[J]. Lancet Reg Health West Pac, 2024, 51: 101198. DOI: 10.1016/j.lanwpc.2024.101198.
|
| [34] |
AKUSHEVICH I, YASHKIN A, UKRAINTSEVA S, et al. The construction of a multidomain risk model of Alzheimer's disease and related dementias[J]. J Alzheimers Dis, 2023, 96(2): 535-550.
|
| [35] |
HAINSWORTH A H, MARKUS H S, SCHNEIDER J A. Cerebral small vessel disease, hypertension, and vascular contributions to cognitive impairment and dementia[J]. Hypertension, 2024, 81(1): 75-86. DOI: 10.1161/HYPERTENSIONAHA.123.19943.
|
| [36] |
杨萌柳,曾燕,许浪,等. 老年人失眠及其类型对认知障碍患病影响[J]. 中国公共卫生, 2023, 39(6): 734-739.
|
| [37] |
ARVANITAKIS Z, CAPUANO A W, LAMAR M, et al. Late-life blood pressure association with cerebrovascular and Alzheimer disease pathology[J]. Neurology, 2018, 91(6): e517-525.
|
| [38] |
LEVINE D A, SPRINGER M V, BRODTMANN A. Blood pressure and vascular cognitive impairment[J]. Stroke, 2022, 53(4): 1104-1113. DOI: 10.1161/STROKEAHA.121.036140.
|
| [39] |
OVEISGHARAN S, KIM N, AGRAWAL S, et al. Brain and spinal cord arteriolosclerosis and its associations with cerebrovascular disease risk factors in community-dwelling older adults[J]. Acta Neuropathol, 2023, 145(2): 219-233.
|